13-229
Showing 1 - 25 of 4,889
Healthy Subject Trial in Shanghai (3D229, Placebo)
Completed
- Healthy Subject
- 3D229
- Placebo
-
Shanghai, Hongkou District, ChinaShanghai General hospital
Jun 20, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)
Completed
- Type 2 Diabetes
- Tirzepatide
- Insulin Glargine
-
Blacktown, New South Wales, Australia
- +66 more
Dec 12, 2022
Signs and Symptoms, Digestive Trial in Valinhos (Probiatop, Placebo)
Recruiting
- Signs and Symptoms, Digestive
- Probiatop
- Placebo
-
Valinhos, São Paulo, BrazilA2Z Clinical Centro Avancado de Pesquisa Clinica Eireli
Oct 31, 2022
Outcomes in Tuberculous Patients in Sohag Governorate
Recruiting
- Tuberculosis
- sputum analysis
- lymph node biobsy
-
Sohag, EgyptSohag university Hospital
Nov 15, 2023
Bile cfDNA of Resectable Biliary Tract Carcinomas
Recruiting
- This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile
- Next generation sequencing
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Mar 13, 2023
Prader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia Trial in Brooklyn (Sham Light, Bright Light Therapy)
Not yet recruiting
- Prader-Willi Syndrome
- +5 more
- Sham Light
- Bright Light Therapy
-
Brooklyn, New YorkMaimonides Medical Center
Jul 2, 2023
HIV Trial (Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg)
Completed
- HIV Infections
- Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg
- (no location specified)
May 11, 2022
Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)
Recruiting
- Leukemia
- +2 more
- applying of FLU+CY post-HSCT
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Nov 23, 2023
Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome Trial (NS-229, Placebo)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Churg-Strauss Syndrome
- NS-229
- Placebo
- (no location specified)
Sep 14, 2023
Opioid Dependence, Acute Opioid Withdrawal Syndrome Trial in United States (Lofexidine HCl, Placebo, Open Label Lofexidine HCL)
Completed
- Opioid Dependence
- Acute Opioid Withdrawal Syndrome
- Lofexidine HCl
- +2 more
-
Clovis, California
- +17 more
Mar 11, 2022
Patients Diagnosed With NSAID Sensitivity in Thailand
Completed
- Aspirin Sensitivity
- +7 more
- aspirin, NSAIDs, paracetamol
-
Bangkok, ThailandFaculty of Medicine, Chulalongkorn University
Feb 8, 2022
Colombian Orinoquia: A Retrospective Cohort Trial 2010-2022.
Not yet recruiting
- Hospital Mortality
- Risk factor
- (no location specified)
Feb 12, 2023
Opioid Prescribing Trial in Ann Arbor (Academic detailing)
Not yet recruiting
- Opioid Prescribing
- Academic detailing
-
Ann Arbor, MichiganUniversity of Michigan
Nov 8, 2023
Prone Position, Acute Respiratory Distress Syndrome Trial in Rome (supine position, prone position)
Not yet recruiting
- Prone Position
- Acute Respiratory Distress Syndrome
- supine position
- prone position
-
Rome, ItalyGiorgio Conti
Aug 28, 2023
Chronic Kidney Diseases, Heart Attack, Stroke, Ischemic Trial in Little Rock (Ticagrelor 90mg, Clopidogrel 75mg, Aspirin 81 mg)
Completed
- Chronic Kidney Diseases
- +2 more
- Ticagrelor 90mg
- +2 more
-
Little Rock, Arkansas
- +1 more
Dec 8, 2022
Congenital Cytomegalovirus Infection Trial in United States (Valganciclovir)
Active, not recruiting
- Congenital Cytomegalovirus Infection
-
Birmingham, Alabama
- +8 more
Aug 18, 2022
Plasma Von Willebrand Factor Antigen to A Disintegrin-like and
Not yet recruiting
- Acute on Chronic Liver Failure
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences.
Sep 28, 2023
Ulcerative Colitis Trial in Ukraine, United States (NX-13 250mg IR, NX-13 500mg IR, NX-13 500mg MR)
Completed
- Ulcerative Colitis
- NX-13 250mg IR
- +3 more
-
Huntsville, Alabama
- +30 more
Jan 6, 2023
Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance
Recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 3, 2022
HIV, Hypertension Trial in Kampala (Integrated HIV/HTN care model)
Active, not recruiting
- HIV
- Hypertension
- Integrated HIV/HTN care model
-
Kampala, Central Region, UgandaInfectious Diseases Research Collaboration
Nov 1, 2022